// App-Quantinova.ai

2712 : Prevention of Venous Thromboembolism in Patients with Multiple Myeloma Receiving Immunomodulatory Therapy: Real-World Examination of the Impede Study

Researchers

Presenter

  • Grace Hwang

Principal Investigators

  • Audrea Szabatura

  • Houry Leblebjian

  • Anil Aktas-Samur

  • Jacob P. Laubach

  • Aric D. Parnes

Medical Centers

  • Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA

  • Department of Pharmacy, Dana Farber Cancer Institute, Brookline, MA

  • Department of Imaging, Dana-Farber Cancer Institute, Boston, MA

  • Department of Imaging, Dana-Farber Cancer Institute, Boston, MA

  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

  • Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Arrhythmia

  • Multiple Myeloma

  • Solid malignancies

Biomarkers

  • White Blood Cell

  • Body mass index

Drug/Treatment

  • Warfarin

  • Aspirin

  • Albyl-E

  • Heparin

Outcome

  • N/A

Study Design

  • Multinational

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved